Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.01 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |